A young company in the field of medical devices, ArthroCare, was the public within six months and its stock - after initially performs very well - now reduced. At the same time, the company faces several tactical decisions that can affect the immediate income and, therefore, potentially damage the share price. "Hide
by Michael J. Roberts Source: Harvard Business School 30 pages. Publication Date: December 1, 1997. Prod. #: 898056-PDF-ENG
Related Case Solutions & Analyses:
Mount Everest–1996
Ritz-Carlton Hotel Co.
Integrative Programs in International Business: The Development of Undergraduate Cohort Programs
International Lobbying and The Dow Chemical Company (A)
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
MySpace
The Roulette Wheel
Principals Agents and Partners
Corporate Values and Transformation: Sequel
DoubleClick Buys Abacus (B)
